Lu Alleruzzo, CEO and Tomas Hode, PhD, President & CIO were honored to be invited to present at the Entrepreneurial Seminar Series hosted by The University of Oklahoma Stephenson School of Biomedical Engineering.
Their presentation titled “Development and Commercialization of a Novel Immunostimulant in Combination with Local Ablation for the Treatment of Metastatic Cancers” will take place at 11:00 am on Friday April 4th in the Gallogly Hall, Room 126. Immunophotonics is excited to share our journey and the strides we have made, hoping to inspire future innovators in the field of biomedical engineering.
A special thank you to Wei Chen for the invitation; Lu and Tomas are looking forward to connecting with the SBME faculty and students.
